Eddie Hill1, Nghia H Nguyen1, Alexander S Qian1, Sagar Patel1, Peter L Chen1, Chung-Sang Tse1, Siddharth Singh2. 1. Division of Gastroenterology and Division of Biomedical Informatics, Department of Medicine, University of California San Diego, 9452 Medical Center Dr., ACTRI 1W501, La Jolla, CA, 92093, USA. 2. Division of Gastroenterology and Division of Biomedical Informatics, Department of Medicine, University of California San Diego, 9452 Medical Center Dr., ACTRI 1W501, La Jolla, CA, 92093, USA. sis040@ucsd.edu.
Abstract
BACKGROUND AND AIMS: Patients with inflammatory bowel disease (IBD) frequently experience comorbid psychiatric disorders, which negatively impact quality of life. We characterized the longitudinal burden of hospitalization-related healthcare utilization in adults with IBD with and without comorbid anxiety, depression, or bipolar disorder. METHODS: In the 2017 Nationwide Readmissions Database (NRD), we identified 40,177 patients with IBD who were hospitalized between January 1, 2017 and June 30, 2017 and who were followed until December 31, 2017. In this cohort, we compared the annual burden (i.e., total days spent in hospital), costs, risk of readmission, inpatient mortality, and IBD-related surgery in patients with and without comorbid psychiatric disorders (anxiety, depression, or bipolar disorder). RESULTS: Of the 40,177 adults who were hospitalized for IBD, 25.7% had comorbid psychiatric disorders. Over a 10 month-long period of follow-up, patients with comorbid psychiatric disorders spent more days in the hospital (median, 7 days vs. 5 days, p < 0.01), experienced higher 30-day (31.3 vs. 25.4%; p < 0.01) and 90-day (42.6 vs. 35.3%, p < 0.01) readmission rates, and had higher hospitalization-related costs (median, $41,418 vs. $39,242, p < 0.01). However, they were less likely to undergo IBD-related procedures or surgeries. There were no differences in risk of mortality. On Cox proportional hazard analysis, the presence of comorbid psychiatric disorders was associated with a 16% higher risk of readmission (HR, 1.16; 95% CI, 1.13-1.20) and a 13% higher risk of severe IBD-related hospitalization (HR, 1.13; 95% CI, 1.08-1.16). CONCLUSIONS: In adults with IBD, comorbid psychiatric disorders were independently associated with a higher burden and cost of hospitalization, without an increase in the risk of IBD-related surgery or procedures. Population-based interventions aimed at treating psychiatric comorbidities may decrease the risk of unplanned healthcare utilization.
BACKGROUND AND AIMS: Patients with inflammatory bowel disease (IBD) frequently experience comorbid psychiatric disorders, which negatively impact quality of life. We characterized the longitudinal burden of hospitalization-related healthcare utilization in adults with IBD with and without comorbid anxiety, depression, or bipolar disorder. METHODS: In the 2017 Nationwide Readmissions Database (NRD), we identified 40,177 patients with IBD who were hospitalized between January 1, 2017 and June 30, 2017 and who were followed until December 31, 2017. In this cohort, we compared the annual burden (i.e., total days spent in hospital), costs, risk of readmission, inpatient mortality, and IBD-related surgery in patients with and without comorbid psychiatric disorders (anxiety, depression, or bipolar disorder). RESULTS: Of the 40,177 adults who were hospitalized for IBD, 25.7% had comorbid psychiatric disorders. Over a 10 month-long period of follow-up, patients with comorbid psychiatric disorders spent more days in the hospital (median, 7 days vs. 5 days, p < 0.01), experienced higher 30-day (31.3 vs. 25.4%; p < 0.01) and 90-day (42.6 vs. 35.3%, p < 0.01) readmission rates, and had higher hospitalization-related costs (median, $41,418 vs. $39,242, p < 0.01). However, they were less likely to undergo IBD-related procedures or surgeries. There were no differences in risk of mortality. On Cox proportional hazard analysis, the presence of comorbid psychiatric disorders was associated with a 16% higher risk of readmission (HR, 1.16; 95% CI, 1.13-1.20) and a 13% higher risk of severe IBD-related hospitalization (HR, 1.13; 95% CI, 1.08-1.16). CONCLUSIONS: In adults with IBD, comorbid psychiatric disorders were independently associated with a higher burden and cost of hospitalization, without an increase in the risk of IBD-related surgery or procedures. Population-based interventions aimed at treating psychiatric comorbidities may decrease the risk of unplanned healthcare utilization.
Authors: Brigida Barberio; Mohammad Zamani; Christopher J Black; Edoardo V Savarino; Alexander C Ford Journal: Lancet Gastroenterol Hepatol Date: 2021-03-12
Authors: Mirjam Severs; Marie-Josée J Mangen; Herma H Fidder; Mirthe E van der Valk; Mike van der Have; Ad A van Bodegraven; Cees H M Clemens; Gerard Dijkstra; Jeroen M Jansen; Dirk J de Jong; Nofel Mahmmod; Paul C van de Meeberg; Andrea E van der Meulen-de Jong; Marieke Pierik; Cyriel Y Ponsioen; Marielle J L Romberg-Camps; Peter D Siersema; Bindia Jharap; Janneke C van der Woude; Nicolaas P A Zuithoff; Bas Oldenburg Journal: Inflamm Bowel Dis Date: 2017-09 Impact factor: 5.325
Authors: Laura E Targownik; Eric I Benchimol; Julia Witt; Charles N Bernstein; Harminder Singh; Lisa Lix; Aruni Tennakoon; Antonio Aviña Zubieta; Stephanie Coward; Jennifer Jones; Ellen Kuenzig; Sanjay K Murthy; Geoffrey C Nguyen; Juan Nicolás Peña-Sánchez; Gil Kaplan Journal: Inflamm Bowel Dis Date: 2019-09-18 Impact factor: 5.325
Authors: Alexis Calloway; Robin Dalal; Dawn B Beaulieu; Caroline Duley; Kimberly Annis; Lawrence Gaines; Chris Slaughter; David A Schwartz; Sara Horst Journal: Dig Dis Sci Date: 2017-10-20 Impact factor: 3.199
Authors: Clarence K Zhang; Jennifer Hewett; Jason Hemming; Taneisha Grant; Hongyu Zhao; Clara Abraham; Ioannis Oikonomou; Meera Kanakia; Judy H Cho; Deborah D Proctor Journal: Inflamm Bowel Dis Date: 2013-07 Impact factor: 5.325